Literature DB >> 8291236

Molecular characterization of border disease virus, a pestivirus from sheep.

P Becher1, A D Shannon, N Tautz, H J Thiel.   

Abstract

Three serologically different pestivirus strains isolated from sheep were selected for molecular analysis. cDNA and deduced amino acid sequences of the genomic regions encoding glycoproteins E1 and E2 were obtained from the three strains. A comparison with amino acid sequences of bovine viral diarrhea virus (BVDV) and classical swine fever virus (CSFV) revealed that one of the three ovine pestivirus strains can be grouped together with BVDV. The other two strains, however, were clearly different from both BVDV and CSFV. Surprisingly, the amino acid sequences from these two viruses were more similar to CSFV than to BVDV. The identity between so-called "true" BDV strains at the amino acid level is about 95% for E1 and 86% for E2 and thus similar to homologies found between CSFV strains. For one "true" BDV strain the genomic region encompassing the nonstructural protein p125 was also cloned and sequenced. The respective comparative analysis led to results which are similar to the ones obtained for the two structural glycoproteins. Taken together the data demonstrate that "true" border disease virus strains represent a separate group within the genus pestivirus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8291236     DOI: 10.1006/viro.1994.1065

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  42 in total

1.  Mutations in the 5' nontranslated region of bovine viral diarrhea virus result in altered growth characteristics.

Authors:  P Becher; M Orlich; H J Thiel
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  CRISPR/Cas9-Mediated Knockout of DNAJC14 Verifies This Chaperone as a Pivotal Host Factor for RNA Replication of Pestiviruses.

Authors:  O Isken; A Postel; B Bruhn; E Lattwein; P Becher; N Tautz
Journal:  J Virol       Date:  2019-02-19       Impact factor: 5.103

3.  Deletions of structural glycoprotein E2 of classical swine fever virus strain alfort/187 resolve a linear epitope of monoclonal antibody WH303 and the minimal N-terminal domain essential for binding immunoglobulin G antibodies of a pig hyperimmune serum.

Authors:  M Lin; F Lin; M Mallory; A Clavijo
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  Correlation between point mutations in NS2 and the viability and cytopathogenicity of Bovine viral diarrhea virus strain Oregon analyzed with an infectious cDNA clone.

Authors:  B M Kümmerer; G Meyers
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  Bovine viral diarrhea virus strain Oregon: a novel mechanism for processing of NS2-3 based on point mutations.

Authors:  B M Kümmerer; D Stoll; G Meyers
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

6.  Serine protease of pestiviruses: determination of cleavage sites.

Authors:  N Tautz; K Elbers; D Stoll; G Meyers; H J Thiel
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

7.  Enzyme-linked immunosorbent assay using a virus type-specific peptide based on a subdomain of envelope protein E(rns) for serologic diagnosis of pestivirus infections in swine.

Authors:  J P Langedijk; W G Middel; R H Meloen; J A Kramps; J A de Smit
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

Review 8.  Bovine viral diarrhea virus: biotypes and disease.

Authors:  D Deregt; K G Loewen
Journal:  Can Vet J       Date:  1995-06       Impact factor: 1.008

9.  Processing in the pestivirus E2-NS2 region: identification of proteins p7 and E2p7.

Authors:  K Elbers; N Tautz; P Becher; D Stoll; T Rümenapf; H J Thiel
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Recovery of virulent and RNase-negative attenuated type 2 bovine viral diarrhea viruses from infectious cDNA clones.

Authors:  Christiane Meyer; Martina Von Freyburg; Knut Elbers; Gregor Meyers
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.